PHARMA NORD EXPORT ApS: Financial statements 2013
CVR: 70996510
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
PHARMA NORD EXPORT ApS (CVR 70996510) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 2,270,438 and a net result of DKK 6,252,296 compared with DKK 5,993,591 the year before. That is a decrease of 1.1% compared with the year before. Equity in the 2013 report amounted to DKK 53,026,052. The solvency ratio was 68.8%.
- Gross Profit
- DKK 2,270,438
- Profit/Loss
- DKK 6,252,296
- Equity
- DKK 53,026,052
- Total Assets
- DKK 77,052,762
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 2.3 mio. | 6.3 mio. | 53 mio. | - |
| 2012 | - | 2.3 mio. | 6 mio. | 47.1 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
PHARMA NORD EXPORT ApS has published its annual report for 2012. Gross profit came to DKK 2,294,548, and the net result was DKK 5,993,591.
About PHARMA NORD EXPORT ApS
PHARMA NORD EXPORT ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 1982. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Eli Wallin. The board consists of Michael Christiani Havemann (chair) and Eli Wallin. The company is owned by PHARMCO II ApS and PharmCo III ApS. According to the 2025 annual report, the company had an average of 66 employees. In 2025, the company reported a gross profit of DKK 1,575,000 and a net result of DKK 11,516,000 compared with DKK 6,889,205 the year before. Equity in the 2025 report amounted to DKK 46,928,000.